JENBURKT PHARMACEUTICALS
Back to Cashflow Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-7.08 Cr | ₹-21 Cr | ₹-5.53 Cr | ₹-0.71 Cr | ₹-11 Cr |
What is the latest Cash Flow from Financing Activities ratio of JENBURKT PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-7.08 Cr |
Mar2023 | ₹-21 Cr |
Mar2022 | ₹-5.53 Cr |
Mar2021 | ₹-0.71 Cr |
Mar2020 | ₹-11 Cr |
How is Cash Flow from Financing Activities of JENBURKT PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-7.08 Cr | Negative | |
Mar2023 | ₹-21 Cr | Negative | |
Mar2022 | ₹-5.53 Cr | Negative | |
Mar2021 | ₹-0.71 Cr | Negative | |
Mar2020 | ₹-11 Cr | - |
Compare Cash Flow from Financing Activities of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹500.1 Cr | 1.7% | -7.4% | 37.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,084.0 Cr | -0% | -4.6% | 18.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,384.0 Cr | 8.8% | 5.1% | 64.4% | Stock Analytics | |
CIPLA | ₹118,853.0 Cr | 2.4% | -1.1% | 0.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,143.0 Cr | 2.6% | -9.9% | -0.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,459.0 Cr | 3.6% | -0.1% | 22.7% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | 1.7% |
-7.4% |
37.1% |
SENSEX | 0.7% |
-0.1% |
8.8% |
You may also like the below Video Courses